Medical research at the University of Nottingham

£0 has been raised from 0 donors.

Project Image

You can help us make our next medical breakthrough, faster

We have a history of world-changing innovation in medical research at the University of Nottingham. From the development of MRI, to leading research on antimicrobial resistance, to life-changing work in our cancer research centres, there is so much to be proud of. 

Our researchers are dedicated to finding solutions to the global challenges that face us all – your support can help make that a reality. 

Your support can Alter the course of medicine

There are some innovations that truly change the world for everyone - and MRI is one. 50 years ago, Sir Peter Mansfield published his landmark paper which laid the foundations for MRI – creating a pioneering technology which has helped save the lives of millions. It is estimated that over 60 million, if not many more, MRI scans are performed annually around the world – all helping clinicians and researchers to diagnose and treat a number of conditions and diseases in people of all ages.

The advancements pioneered by MRI are also unlocking exciting new avenues of research. Today, an innovative research team led by Professor Matt Brookes has developed the world’s first wearable magnetoencephalography (MEG) device –a high-quality brain scanner located inside a helmet with the potential to revolutionise brain research as both a neuroscientific and diagnostic tool. 

“This team have created a scanner that works while the wearer is mobile. This innovation, which exploits magnetic coil designs that were originally used in MRI, is creating so many new possibilities – we can start to answer questions like: why do we fall more as we get older and what happens in the brains of infants as they grow?”

– Richard Bowtell, Director of Sir Peter Mansfield Imaging Centre

This helmet is not the only transformative medical device created at Nottingham. Professor Stephen Jackson and team have created a new, non-invasive wrist device for people with Tourettes Syndrome. Called Neupulse, it is proving to be effective at reducing the severity and frequency of tics, giving people more control over their symptoms.

“Though the Neupulse device is still early in development, the results of this UK-wide double-blind clinical trial have been extremely encouraging. This device has the potential to dramatically improve the lives of those with Tourette syndrome, who often face challenges managing their tics, by providing increased control over their tics on demand.”

– Professor Stephen Jackson from the University of Nottingham and Chief Scientific Officer at Neurotherapeutics Ltd

How you can help

Innovations like these with the power to transform people’s lives requires vision, endeavour, belief and backing. With focused minds – and open eyes – just like Sir Peter Mansfield 50 years ago, our researchers can develop and deliver advancements that improve our health and wellbeing. Your backing can help us get there.

Donate today and you can be a catalyst for change.

Spread the word

Let's get this started! Be the first to make a donation